单源性高血压与氨酸-氨酸-阿尔多斯特系统相关
1Division of General Internal Medicine, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye;Hacettepe University, Center for Genomics and Rare Diseases, Ankara, Türkiye.
Anatolian journal of cardiology
|June 14, 2024
概括
单一性高血压是由氨酸- ангиотензин- алдостерон系统 (RAAS) 的遗传突变引起的,需要精确的诊断和向治疗,如道阻塞剂. 了解这些罕见的遗传疾病是控制血压和预防并发症的关键.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 心血管医学 心血管医学
背景情况:
- 单一性高血压涉及罕见的基因突变,破坏了氨酸- ангиотензин-阿尔多斯特系统 (RAAS).
- 这些疾病,包括戈登综合征和利德尔综合征,导致不同的形式的遗传性高血压.
- 早期出现的高血压,电解质失衡和pH异常是关键指标.
研究的目的:
- 审查RAAS途径中的生殖系突变,导致单基性高血压.
- 突出这些罕见疾病的临床特征,诊断挑战和治疗策略.
- 强调基因测序对于准确诊断和个性化治疗的重要性.
主要方法:
- 关于孟德尔形式的RAAS相关高血压的文献综述.
- 分析特定单一性高血压综合征的病理生理机制.
- 讨论诊断方法,包括下一代测序.
- 评估治疗影响和管理策略.
主要成果:
- 确定了导致明显遗传性高血压类型的特定遗传突变.
- 详细的独特的临床表现和诊断挑战.
- 突出了特异性治疗的有效性,如 thiazides 和低剂量皮质类固醇.
- 强调基因检测在指导个性化治疗计划中的作用.
结论:
- 准确诊断单一性高血压依赖于识别特定的临床症状和家族病史.
- 下一代测序对于识别致病性遗传突变至关重要.
- 包括通道阻塞剂在内的向治疗对于管理RAAS相关的高血压和预防严重后果至关重要.
- 基因理解的进步有望改善对这些复杂疾病的管理.
相关概念视频
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
567
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
567
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
611
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
611
01:17Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
706
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
706